Teva Announces European Medicines Agency (EMA) Confirms Successful Validation of Reslizumab Marketing Authorization Application

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Teva Announces European Medicines Agency (EMA) Confirms Successful Validation of Reslizumab Marketing Authorization Application
TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 32.20 +0.72 (2.29%)
Previous Close $31.48    52 Week High $66.55 
Open $31.37    52 Week Low $37.82 
Day High $32.39    P/E N/A 
Day Low $31.28    EPS $0.00 
Volume 6,111,090